+157.2%
MRNA vs INFY
-18.8%
+176.0%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | INFY | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +1.5% | +3.9% | +4.5% |
| 7D | -1.1% | -5.4% | +4.3% | +2.1% |
| 30D | +126.1% | -9.9% | +136.0% | +138.0% |
| 3M | +190.0% | -4.6% | +194.6% | +199.8% |
| 6M | +157.2% | -18.5% | +175.7% | +180.5% |
| All | +157.2% | -18.8% | +176.0% | +180.5% |
Cumulative growth
Daily Returns
Daily percentage return beside INFY.
Daily Out/Under-Performance
Portfolio return minus INFY return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × INFY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded INFY wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling